Supplements

A Federal Practitioner Exclusive

Topics Include:

• Asthma
• Traumatic Brain Injury
• Dementia
• Post-Traumatic Stress Disorder
• Pain
• Migraine
• Suicide/Suicide Prevention
• Depression
• Anxiety
• Substance Use Disorder
• Tobacco
• Diabetes/Cardiovascular Disease
• Diabetic Retinopathy
• COVID-19
• Vaccination
• HIV
• Cancer Screening
  
  To read the supplement click on the cover image or here 

A Federal Practitioner Exclusive

Topics Include:

• Asthma
• Traumatic Brain Injury
• Dementia
• Post-Traumatic Stress Disorder
• Pain
• Migraine
• Suicide/Suicide Prevention
• Depression
• Anxiety
• Substance Use Disorder
• Tobacco
• Diabetes/Cardiovascular Disease
• Diabetic Retinopathy
• COVID-19
• Vaccination
• HIV
• Cancer Screening
  
  To read the supplement click on the cover image or here 

A Federal Practitioner Exclusive

Topics Include:

• Asthma
• Traumatic Brain Injury
• Dementia
• Post-Traumatic Stress Disorder
• Pain
• Migraine
• Suicide/Suicide Prevention
• Depression
• Anxiety
• Substance Use Disorder
• Tobacco
• Diabetes/Cardiovascular Disease
• Diabetic Retinopathy
• COVID-19
• Vaccination
• HIV
• Cancer Screening
  
  To read the supplement click on the cover image or here 

Acne & Rosacea

• Rosacea phenotypes
• Erythema and flushing
• Aggressive treatment of acne
• Energy-based rosacea therapy
• Diet and acne

Acne & Rosacea

• Rosacea phenotypes
• Erythema and flushing
• Aggressive treatment of acne
• Energy-based rosacea therapy
• Diet and acne

Acne & Rosacea

• Rosacea phenotypes
• Erythema and flushing
• Aggressive treatment of acne
• Energy-based rosacea therapy
• Diet and acne

Pediatric Dermatology: A Supplement to Pediatric News & Dermatology News

Table of Contents:

• Dupilumab curbed itch intensity, frequency in children with severe eczema
• Vitiligo treatment options abound but consider patient goals
• Beware a pair of dermatologic emergencies in children
• Database offers snapshot of common causes of pediatric allergic contact dermatitis
• Who’s at risk for depression on isotretinoin?
• Expert shares his approach to treating warts in children

Pediatric Dermatology: A Supplement to Pediatric News & Dermatology News

Table of Contents:

• Dupilumab curbed itch intensity, frequency in children with severe eczema
• Vitiligo treatment options abound but consider patient goals
• Beware a pair of dermatologic emergencies in children
• Database offers snapshot of common causes of pediatric allergic contact dermatitis
• Who’s at risk for depression on isotretinoin?
• Expert shares his approach to treating warts in children

Pediatric Dermatology: A Supplement to Pediatric News & Dermatology News

Table of Contents:

• Dupilumab curbed itch intensity, frequency in children with severe eczema
• Vitiligo treatment options abound but consider patient goals
• Beware a pair of dermatologic emergencies in children
• Database offers snapshot of common causes of pediatric allergic contact dermatitis
• Who’s at risk for depression on isotretinoin?
• Expert shares his approach to treating warts in children

Sleep Medicine A Special Report

• MOBILE PHONE RELIANCE
  How it’s linked to young adults’ sleep problems in two studies
• OBSTRUCTIVE SLEEP APNEA
  New research validates phenotypes in Latinos 
• DEMENTIA
  Papers show associations between disease and sleep therapies

Sleep Medicine A Special Report

• MOBILE PHONE RELIANCE
  How it’s linked to young adults’ sleep problems in two studies
• OBSTRUCTIVE SLEEP APNEA
  New research validates phenotypes in Latinos 
• DEMENTIA
  Papers show associations between disease and sleep therapies

Sleep Medicine A Special Report

• MOBILE PHONE RELIANCE
  How it’s linked to young adults’ sleep problems in two studies
• OBSTRUCTIVE SLEEP APNEA
  New research validates phenotypes in Latinos 
• DEMENTIA
  Papers show associations between disease and sleep therapies

Federal Practitioner Supplement: Advances in Hematology and Oncology

• Impact of an Oral Antineoplastic Renewal Clinic
• Implementing Comprehensive Geriatric Assessments for Oncology Patients
• Radiation Toxicity and Survival in Patients with Presumed Early-Stage NCSLC
• Screening High-Risk Women Veterans for Breast Cancer
• Standardizing the Discharge Process for Inpatient Hem/Onc
• Massive Retroperitoneal Liposarcoma Masquerading as Meralgia Paresthetica
• Delayed Coronary Vasospasm in Metastatic Gastric Cancer

THIS ISSUE WAS PRODUCED IN COLLABORATION WITH AVAHO

Federal Practitioner Supplement: Advances in Hematology and Oncology

• Impact of an Oral Antineoplastic Renewal Clinic
• Implementing Comprehensive Geriatric Assessments for Oncology Patients
• Radiation Toxicity and Survival in Patients with Presumed Early-Stage NCSLC
• Screening High-Risk Women Veterans for Breast Cancer
• Standardizing the Discharge Process for Inpatient Hem/Onc
• Massive Retroperitoneal Liposarcoma Masquerading as Meralgia Paresthetica
• Delayed Coronary Vasospasm in Metastatic Gastric Cancer

THIS ISSUE WAS PRODUCED IN COLLABORATION WITH AVAHO

Federal Practitioner Supplement: Advances in Hematology and Oncology

• Impact of an Oral Antineoplastic Renewal Clinic
• Implementing Comprehensive Geriatric Assessments for Oncology Patients
• Radiation Toxicity and Survival in Patients with Presumed Early-Stage NCSLC
• Screening High-Risk Women Veterans for Breast Cancer
• Standardizing the Discharge Process for Inpatient Hem/Onc
• Massive Retroperitoneal Liposarcoma Masquerading as Meralgia Paresthetica
• Delayed Coronary Vasospasm in Metastatic Gastric Cancer

THIS ISSUE WAS PRODUCED IN COLLABORATION WITH AVAHO

New Supplement to Federal Practitioner: Advances in Neurology

Read more about:

• Lumbar Fusion With PEEK Rods Use for Patients With Degenerative Disease
• Systemic Literature Review of the Use of Virtual Reality for Rehabilitation in Parkinson Disease
• COVID-19 Vaccine in Veterans With Multiple Sclerosis: Protect the Vulnerable

Click here to read the supplement or click on the image

New Supplement to Federal Practitioner: Advances in Neurology

Read more about:

• Lumbar Fusion With PEEK Rods Use for Patients With Degenerative Disease
• Systemic Literature Review of the Use of Virtual Reality for Rehabilitation in Parkinson Disease
• COVID-19 Vaccine in Veterans With Multiple Sclerosis: Protect the Vulnerable

Click here to read the supplement or click on the image

New Supplement to Federal Practitioner: Advances in Neurology

Read more about:

• Lumbar Fusion With PEEK Rods Use for Patients With Degenerative Disease
• Systemic Literature Review of the Use of Virtual Reality for Rehabilitation in Parkinson Disease
• COVID-19 Vaccine in Veterans With Multiple Sclerosis: Protect the Vulnerable

Click here to read the supplement or click on the image

Read the supplement here or by clicking on the image

Elevations in serum neurofilament light chain levels in people with multiple sclerosis (MS) are significantly linked to worse neurologic function, clinical disability, and lower brain volumes, according to new findings from a large, diverse population of patients with MS. “This is one of the largest studies to evaluate serum neurofilament light chain levels in people with MS,” said lead author Elias S. Sotirchos, MD, an assistant professor of neurology at Johns Hopkins University, Baltimore. “An important strength of this cohort is that it is a realworld cohort of patients followed in U.S. and European MS centers,” he said. “The study captures the diversity of the MS population, including demographics, comorbidities, lifestyle factors, and clinical characteristics that may otherwise not be captured in a clinical trial population.” The research was presented at the 2021 ACTRIMS Forum.

Read the supplement here or by clicking on the image

Elevations in serum neurofilament light chain levels in people with multiple sclerosis (MS) are significantly linked to worse neurologic function, clinical disability, and lower brain volumes, according to new findings from a large, diverse population of patients with MS. “This is one of the largest studies to evaluate serum neurofilament light chain levels in people with MS,” said lead author Elias S. Sotirchos, MD, an assistant professor of neurology at Johns Hopkins University, Baltimore. “An important strength of this cohort is that it is a realworld cohort of patients followed in U.S. and European MS centers,” he said. “The study captures the diversity of the MS population, including demographics, comorbidities, lifestyle factors, and clinical characteristics that may otherwise not be captured in a clinical trial population.” The research was presented at the 2021 ACTRIMS Forum.

Read the supplement here or by clicking on the image

Elevations in serum neurofilament light chain levels in people with multiple sclerosis (MS) are significantly linked to worse neurologic function, clinical disability, and lower brain volumes, according to new findings from a large, diverse population of patients with MS. “This is one of the largest studies to evaluate serum neurofilament light chain levels in people with MS,” said lead author Elias S. Sotirchos, MD, an assistant professor of neurology at Johns Hopkins University, Baltimore. “An important strength of this cohort is that it is a realworld cohort of patients followed in U.S. and European MS centers,” he said. “The study captures the diversity of the MS population, including demographics, comorbidities, lifestyle factors, and clinical characteristics that may otherwise not be captured in a clinical trial population.” The research was presented at the 2021 ACTRIMS Forum.